Pacing and cardioversion lead systems with shared lead conductors

• US 5,336,253 A
• Filed: 02/23/1993
• Issued: 08/09/1994
• Est. Priority Date: 02/23/1993
• Status: Expired due to Term

• Current Assignee: Reed A. Duthler
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Meador, John T., Mehra, Rahul, Keimel, John G., Gordon, Pat L.
• Primary Examiner(s): Cohen, Lee S.
• Application Number:
  US08/021,408
• Time in Patent Office: 532 Days
• Field of Search: 607/122, 607/123, 607/125-131, 607/4
• US Class Current: 607/122
• CPC Class Codes: A61N 1/056 Transvascular endocardial electrode systems

Abstract

A combined pacing and cardioversion lead system with internal electrical switching components for unipolar or bipolar sensing of electrograms, pacing at normal pacing voltages and cardioversion or defibrillation. In bipolar embodiments, an indifferent electrode, closely spaced to a sensing and pacing electrode, is coupled in common through the integral switching circuitry to a large surface area cardioversion electrode. In these embodiments, pacing and sensing is accomplished through a pair of conductors extending through the lead system to the closely spaced active and indifferent electrode pair. When cardioversion energy is applied to the indifferent electrode, the cardioversion energy is also directed to the cardioversion electrode through operation of the switching circuitry in response to the magnitude of the applied cardioversion pulse. In unipolar embodiments, a distal sensing and pacing electrode is coupled through integral switching circuitry to a large surface area cardioversion electrode. In these embodiments, only a single conductor extending through the lead to the pacing and sensing electrode is required. When cardioversion energy is applied to the pacing and sensing electrode, the cardioversion energy is also directed to the cardioversion electrode through operation of the switching circuitry in response to the magnitude of the applied cardioversion pulse.

Claims

1. A cardioversion and pacing lead for implantation in or on a human heart, comprising:

an elongated insulated lead body;

a first conductor, having a proximal end and a distal end, mounted in said lead body;

a second conductor, having a proximal end and a distal end, mounted within said lead body, insulated from said first conductor;

a first connector, coupled to the proximal end of said first conductor;

a second connector, coupled to the proximal end of said second conductor;

a first electrode, exposed to the exterior of said lead body and coupled to the distal end of said first conductor for applying electrical energy to and sensing heart signals from heart tissue;

a second electrode exposed to the exterior of said lead body and coupled to the distal end of said second conductor for applying electrical energy to and sensing heart signals from heart tissue;

a third electrode exposed to the exterior of said lead body for applying electrical energy to heart tissue; and

switching means within said lead body coupled between said second conductor and said third electrode for directing the electrical energy of a cardioversion pulse applied to said second connector in common to said second and third electrodes and to said heart tissue, while preventing the electrical energy of a pacing pulse applied to said first and second connectors from being directed to the third electrode.

2. A cardioversion and pacing lead according to claim 1 further comprising energy-limiting means coupled to said second electrode and conductor for preventing the electrical energy of a said cardioversion pulse from exceeding a maximum energy level at said second electrode.

3. A cardioversion and pacing lead according to claim 1 wherein said switching means further comprises a pair of series connected, back-to-back zener diodes having breakover conduction voltages selected to switch said diodes into conduction only when a cardioversion voltage and current is applied to said second connector.

4. A cardioversion and pacing lead according to claim 3 wherein said switching means further comprises a thyristor and zener diode surge suppression circuit.

5. A cardioversion and pacing lead for implantation in or on a human heart, comprising:

an elongated insulated lead body;

a conductor, having a proximal end and a distal end, mounted in said lead body;

a connector, coupled to the proximal end of said conductor;

a first electrode, exposed to the exterior of said lead body and coupled to the distal end of said conductor for applying electrical energy to and sensing heart signals from heart tissue;

a second electrode exposed to the exterior of said lead body for applying electrical energy to heart tissue; and

switching means within said lead body, responsive to the delivery of a cardioversion pulse to said first electrode, coupled between said first and second electrodes for applying electrical energy of a cardioversion pulse applied to said first electrode to said second electrode and to said heart tissue, while preventing application of electrical energy of a pacing pulse applied to said first electrode to said second electrode.

6. A cardioversion and pacing lead according to claim 5 further comprising energy-limiting means coupled between said first and second electrodes for preventing electrical energy of a said cardioversion pulse from exceeding a maximum energy level at said first electrode.

7. A cardioversion and pacing lead according to claim 5 wherein said switching means further comprises a pair of series connected, back-to-back zener diodes having breakover conduction voltages selected to switch said diodes into conduction only when a cardioversion voltage and current is applied to said first electrode.

8. A cardioversion and pacing lead according to claim 7 wherein said switching means further comprises a thyristor and zener diode surge suppression circuit.